Part 1 of this pre-conference workshop provides a review on how drug action, absorption, distribution, metabolism, and elimination change during the aging process, with case studies used to illustrate concepts. Strategies are discussed that can promote safe medication management and prescribing in older adults. Part 2 of this pre-conference workshop focuses on how anticoagulation treatment decisions in the elderly are challenging, as this population is at a high risk for thrombotic events and anticoagulation-associated bleeding. The clinical profiles of the various anticoagulant drug classes are reviewed, including a detailed look at the newly approved target-specific oral anticoagulant drugs.

Contact hours available until 10/3/2017.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure:
Faculty, planners, authors, and speakers have no disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.

Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.

Objectives:
1. Describe the pharmacology of common medications used to treat diabetes.
2. Examine how physiological and environmental changes brought on by aging affect drug choices for diabetes.
3. Design appropriate medical interventions for elders with diabetes.
4. Illustrate common challenges in caring for patients with diabetes.
5. Compare and contrast the clinical profiles of currently available anticoagulants.
6. Review patient characteristics and other factors that influence the choice of anticoagulation therapy.
7. Identify contraindications to the newly approved target-specific oral anticoagulants and discuss limitations of their utilization in the elderly population.

Products